Stock listing
gettex:G49N GenSight Biologics SA Aktie
German listing (gettex) of GenSight Biologics SA · home listing Euronext:SIGHT
Follow GenSight Biologics SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:SIGHT
€0.077 EUR +0.008 (+11.8%)
Close on Nov 9, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:SIGHT
- Day range
- €0.069 – €0.082 EURNov 9, 2026
- Volume
- 1.09M sharesNov 9, 2026
- Market cap
- €18.98M EURAt the close on Nov 9, 2026 · price × 245.3M shares outstanding
- 52-week range
- €0.060 – €0.149 EURLowest and highest trades, Nov 10, 2025 – Nov 9, 2026
- Traded on an average day
- €174,622 EURMedian day 1.06M shares · last 3 months, Aug 10, 2026 – Nov 9, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:SIGHT · Home | €0.077 EUR | +0.008 (+11.8%) | 1,092,977 | €0.069 | €0.082 | €0.069 | €0.069 | Close on Nov 9, 2026 |
| LSE:0RIM | €0.078 EUR | +0.008 (+11.5%) | 389,259 | €0.069 | €0.080 | €0.069 | €0.070 | Close on Nov 9, 2026 |
| Frankfurt:G49N | €0.063 EUR | +0.001 (+1.1%) | — | €0.063 | €0.063 | €0.063 | €0.062 | Close on Nov 9, 2026 |
Daily closes
Last 3 months, Aug 10, 2026 – Nov 9, 2026 · EURONEXT:SIGHT · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.077 | +0.008 | +11.8% | €0.069 | €0.082 | €0.069 | 1,092,977 | |
| €0.069 | +0.000 | +0.3% | €0.072 | €0.072 | €0.069 | 148,304 | |
| €0.069 | 0.000 | -0.3% | €0.071 | €0.073 | €0.069 | 464,008 | |
| €0.069 | -0.002 | -3.4% | €0.071 | €0.072 | €0.060 | 2,188,606 | |
| €0.072 | -0.002 | -2.1% | €0.073 | €0.073 | €0.071 | 721,202 | |
| €0.073 | -0.004 | -5.3% | €0.070 | €0.077 | €0.070 | 631,782 | |
| €0.077 | +0.003 | +3.9% | €0.076 | €0.081 | €0.074 | 593,657 | |
| €0.074 | -0.001 | -1.1% | €0.075 | €0.076 | €0.073 | 534,980 | |
| €0.075 | +0.003 | +4.0% | €0.071 | €0.076 | €0.070 | 943,178 | |
| €0.072 | -0.001 | -1.0% | €0.073 | €0.073 | €0.071 | 275,556 | |
| €0.073 | +0.003 | +4.0% | €0.070 | €0.073 | €0.069 | 815,207 | |
| €0.070 | -0.003 | -4.5% | €0.073 | €0.073 | €0.070 | 610,393 | |
| €0.073 | 0.000 | 0.0% | €0.073 | €0.075 | €0.072 | 481,900 | |
| €0.073 | -0.002 | -3.2% | €0.075 | €0.075 | €0.072 | 590,489 | |
| €0.076 | +0.005 | +7.4% | €0.071 | €0.076 | €0.069 | 1,288,749 | |
| €0.071 | -0.002 | -2.2% | €0.073 | €0.074 | €0.070 | 683,873 | |
| €0.072 | -0.004 | -5.0% | €0.076 | €0.076 | €0.072 | 1,036,692 | |
| €0.076 | +0.005 | +7.3% | €0.071 | €0.076 | €0.069 | 2,443,235 | |
| €0.071 | +0.001 | +0.9% | €0.070 | €0.071 | €0.067 | 1,670,580 | |
| €0.070 | -0.004 | -5.8% | €0.075 | €0.075 | €0.070 | 1,139,033 | |
| €0.075 | -0.002 | -2.0% | €0.076 | €0.078 | €0.074 | 1,054,685 | |
| €0.076 | -0.004 | -5.4% | €0.080 | €0.080 | €0.075 | 1,210,309 | |
| €0.080 | -0.003 | -3.0% | €0.085 | €0.086 | €0.074 | 3,658,484 | |
| €0.083 | +0.003 | +3.5% | €0.080 | €0.087 | €0.080 | 1,619,455 | |
| €0.080 | 0.000 | -0.1% | €0.080 | €0.086 | €0.079 | 1,715,788 | |
| €0.080 | -0.004 | -4.3% | €0.084 | €0.084 | €0.072 | 2,933,860 | |
| €0.084 | -0.004 | -4.2% | €0.082 | €0.086 | €0.072 | 3,728,605 | |
| €0.087 | -0.012 | -12.1% | €0.095 | €0.099 | €0.087 | 2,108,978 | |
| €0.099 | -0.014 | -12.7% | €0.110 | €0.110 | €0.099 | 3,565,546 | |
| €0.114 | -0.005 | -4.2% | €0.120 | €0.120 | €0.114 | 965,335 | |
| €0.119 | -0.004 | -3.3% | €0.125 | €0.125 | €0.118 | 1,228,214 | |
| €0.123 | -0.009 | -7.0% | €0.133 | €0.135 | €0.121 | 2,687,582 | |
| €0.132 | +0.001 | +0.8% | €0.130 | €0.142 | €0.130 | 3,207,790 | |
| €0.131 | +0.015 | +12.9% | €0.118 | €0.131 | €0.117 | 2,320,182 | |
| €0.116 | +0.006 | +5.6% | €0.109 | €0.117 | €0.109 | 1,060,056 | |
| €0.110 | +0.001 | +1.1% | €0.108 | €0.111 | €0.107 | 672,619 | |
| €0.109 | -0.001 | -0.5% | €0.109 | €0.109 | €0.109 | 307,644 | |
| €0.109 | -0.002 | -1.6% | €0.111 | €0.111 | €0.108 | 775,748 | |
| €0.111 | -0.007 | -5.8% | €0.117 | €0.117 | €0.111 | 919,585 | |
| €0.118 | -0.001 | -0.5% | €0.119 | €0.124 | €0.116 | 1,196,489 | |
| €0.118 | +0.007 | +6.3% | €0.113 | €0.125 | €0.112 | 2,778,890 | |
| €0.111 | 0.000 | 0.0% | €0.112 | €0.112 | €0.110 | 726,563 | |
| €0.111 | -0.001 | -0.5% | €0.112 | €0.112 | €0.111 | 640,080 | |
| €0.112 | -0.002 | -2.1% | €0.112 | €0.114 | €0.111 | 919,496 | |
| €0.114 | +0.008 | +7.1% | €0.115 | €0.129 | €0.111 | 5,544,913 | |
| €0.107 | +0.001 | +0.6% | €0.107 | €0.107 | €0.105 | 291,311 | |
| €0.106 | -0.003 | -2.4% | €0.109 | €0.109 | €0.102 | 899,035 | |
| €0.109 | -0.008 | -7.2% | €0.118 | €0.118 | €0.098 | 4,681,897 | |
| €0.117 | -0.002 | -1.8% | €0.119 | €0.119 | €0.117 | 392,254 | |
| €0.119 | -0.004 | -2.9% | €0.125 | €0.125 | €0.119 | 1,325,516 | |
| €0.123 | -0.002 | -1.6% | €0.126 | €0.126 | €0.122 | 699,149 | |
| €0.125 | -0.001 | -1.0% | €0.127 | €0.127 | €0.124 | 2,021,011 | |
| €0.126 | +0.008 | +6.9% | €0.119 | €0.127 | €0.118 | 2,768,712 | |
| €0.118 | -0.002 | -2.0% | €0.121 | €0.121 | €0.117 | 834,284 | |
| €0.120 | -0.004 | -2.9% | €0.125 | €0.125 | €0.115 | 2,553,754 | |
| €0.124 | +0.009 | +8.0% | €0.118 | €0.134 | €0.115 | 4,719,570 | |
| €0.115 | +0.010 | +9.1% | €0.105 | €0.118 | €0.102 | 2,580,289 | |
| €0.105 | -0.003 | -2.6% | €0.108 | €0.108 | €0.103 | 993,428 | |
| €0.108 | +0.003 | +3.3% | €0.104 | €0.111 | €0.098 | 2,495,577 | |
| €0.105 | -0.009 | -8.2% | €0.118 | €0.119 | €0.102 | 2,721,336 | |
| €0.114 | +0.017 | +16.9% | €0.098 | €0.125 | €0.098 | 10,186,213 | |
| €0.098 | +0.010 | +11.9% | €0.087 | €0.098 | €0.087 | 4,441,608 | |
| €0.087 | +0.002 | +2.8% | €0.085 | €0.087 | €0.084 | 442,864 | |
| €0.085 | +0.000 | +0.1% | €0.085 | €0.085 | €0.084 | 474,352 | |
| €0.085 | -0.002 | -1.7% | €0.086 | €0.086 | €0.084 | 784,399 | |
| €0.086 | -0.002 | -2.2% | €0.087 | €0.087 | €0.085 | 719,712 |
- Ticker
- gettex:G49N
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 16, 2026
GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders
Latest deck · May 19, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides
Latest news
GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders
Oct 16, 2026
Closed €0.071 (-2.2%) on Oct 19, 2026
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa
Oct 8, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders
Oct 8, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Reports Cash Position as of September 30, 2026
Oct 7, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics S A Reports Cash Position as of September 30, 2026
Oct 7, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
Sep 30, 2026
Closed €0.099 (-12.7%) on Sep 30, 2026
GenSight Biologics publie ses résultats financiers du premier semestre 2026 et fait un point sur son activité
Sep 30, 2026
Closed €0.099 (-12.7%) on Sep 30, 2026
GenSight Biologics Provides September 2026 Business Updates
Sep 8, 2026
Closed €0.114 (+7.1%) on Sep 8, 2026
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
Jul 8, 2026
Closed €0.083 (-1.7%) on Jul 9, 2026
GenSight Biologics Announces the Results of its Combined General Meeting of May 19, 2026
May 20, 2026
Closed €0.087 (-0.2%) on May 21, 2026
Financings
Private placement of ordinary shares, pre-funded warrants and investor warrants
Oct 16, 2026
Closed: €1M in the latest tranche · €0.077 a share · Warrants at €0.0497 for 60 months
Buyers: Heights Capital; Invus
Use of proceeds: Operating activities and working capital pending the structural financing of the RECOVER Phase III trial
Private placement of ordinary shares, pre-funded warrants and investor warrants
Jan 7, 2026 · US$3.38M
Closed: €2.89M raised · €0.08 a share · Warrants at €0.11 for 60 months
Buyers: Heights Capital; Invus; Alumni Capital
Use of proceeds: About 73% to develop GS010/LUMEVOQ; balance for financial obligations incl. EUR 0.7m convertible bond redemption
Private placement of ordinary shares, pre-funded warrants and investor warrants
Nov 13, 2025 · US$2.33M
Closed: €2M raised · €0.1045 a share · Warrants at €0.21 for 56 months · Maxim Group, LLC
Dealers: Maxim Group, LLC
Buyers: Invus (existing shareholder; 13.3% of share capital after issuance of the Offered Shares); Alumni Capital (existing shareholder; 7.5% of share capital after issuance of the Offered Shares)
Use of proceeds: Up to about 92% of net proceeds to fund continued development of GS010/LUMEVOQ, including tech transfer, regulatory work and study preparations
Private placement of ordinary shares, pre-funded warrants and investor warrants
Oct 1, 2025 · US$4.34M
Closed: €3.69M raised · €0.12 a share · Warrants at €0.21 for 58 months · Maxim Group, LLC
Dealers: Maxim Group, LLC
Buyers: Heights Capital (subscription of EUR 0.7 million offset against repayment of convertible bond principal); Invus; Alumni Capital
Use of proceeds: EUR 0.7 million used to repay principal on convertible bonds held by Heights Capital through offset against their subscription
Private placement of ordinary shares, pre-funded warrants and investor warrants
Jul 3, 2025 · US$4.59M
Closed: €3.91M raised · €0.17 a share · Warrants at €0.21 for 60 months · Maxim Group, LLC
Dealers: Maxim Group, LLC (lead)
Buyers: Heights Capital (EUR 0.7 million subscription offset against repayment of convertible bonds)
Use of proceeds: EUR 0.7 million used to repay principal on convertible bonds held by Heights Capital
Decks
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides · May 19, 2026
Investor Presentation (October 2025)
Investor deck · 26 slides · October 2025
Investor Presentation (May 2025)
Investor deck · 26 slides · May 2025
Investor Presentation (September 2024)
Investor deck · 22 slides · September 2024
GenSight Biologics SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 48 in all · newest Oct 16, 2026 · oldest 2025
- Decks
- 20 decks · latest May 19, 2026
Where GenSight Biologics SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:SIGHT · Home listing | Euronext | France | EUR |
| LSE:0RIM | LSE | United Kingdom | EUR |
| gettex:G49N · This page | gettex | Germany | EUR |
| LS Exchange:A2ANGZ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2ANGZ | Lang & Schwarz | Germany | EUR |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| OTC:GSGTF | OTC | United States | USD |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| Dusseldorf:G49N | Dusseldorf | Germany | EUR |
| Frankfurt:G49N | Frankfurt | Germany | EUR |
| Hamburg:G49N | Hamburg | Germany | EUR |
| Munich:G49N | Munich | Germany | EUR |
| Stuttgart:G49N | Stuttgart | Germany | EUR |
| Turquoise:SIGHTP | Turquoise | United Kingdom | EUR |
Log in to ask 6ix AI your own questions about GenSight Biologics SA.